CreatorsPublishersAdvertisers
View more in
Medical & Biotech

AbbVie bets big on a gene therapy for eye diseases

biopharmadive.com
 2021-09-13

Cover picture for the articleAbbVie is willing to pay billions of dollars for access to an experimental gene therapy from Regenxbio, a Maryland-based drugmaker, that's being tested as a treatment for several prominent eye diseases. Through a collaboration announced Monday, AbbVie will initially trade $370 million in exchange for global rights to develop...

www.biopharmadive.com

Comments / 0

Comments / 0